Transcutaneous Vagus Nerve Stimulation Device for patient use

tVNS Health GmbH

Grünwald, Germany

tVNS Health Gmbh , medical technology sales company based in Grünwald – Germany, has been the distribution and service gateway to a game-changer non-invasive neuromodulation product - tVNS® in Eastern Europe, Scandinavia, Asia, Africa, Oceania, South America and Italy. tVNS® , developed and manufactured in Germany, is the world's only non-invasive vagus nerve stimulation device approved as a Class IIa medical device under the EU-MDR, offering a scientifically validated treatment for conditions related to sympathovagal imbalance. Transcutaneous vagus nerve stimulation is an electrical stimulation method using the biolectric to treat neurological disorders. Treatment with tVNS® transcutaneous vagus nerve stimulation device is characterized by its simplicity and adaptability to everyday life. At its core, tVNS® operates on the principle of neurostimulation, a process that engages the vagus nerve s capacity to influence various bodily functions and systems. tVNS® stimulates the auricular branch of the vagus nerve (ABVN) through the skin with gentle and precise electrical impulses that propagate therapeutic signals to the brain, first to the brain stem and then to higher centers, aiming to correct dysregulation within the nervous system. tVNS® is indicated to treat the following conditions: Anxiety, Atrial Fibrillation, Autism, Cognitive Impairment, Depression , Epilepsy, Inflammatory Bowel Syndrome, Irritable Bowel Disease Migraines, Parkinson's Disease, Prader-Willi-Syndrome, Sleep Disorders, Systemic Sclerosis and Tinnitus. Please contact info@tvns.health for distribution queries and purchase options of tVNS®.